Blog Post Discusses CEPI’s Efforts To Standardize COVID-19 Vaccine Development

CEPI: Why and how do we harmonize assessment of COVID-19 vaccine trials?
Jodie Rogers, communications manager at CEPI, writes, “We spoke to Valentina Bernasconi, Preclinical and Immunology Scientist in CEPI’s Vaccine R&D Team and Project Leader of the Centralised Laboratory Network, about the role of biological standardization in vaccine development, CEPI’s work within this area, and how the new global lab network will operate…” (10/2).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.